natural joint health and skin & coat products for your pets
"Sea" the difference with Sea Pet
Shop at Sea Pet
online store
Bibliography of additional articles
The following is a partial list of additional articles from scientific journals discussing the benefits and attributes of shark cartilage.
Oikawa, T., A Novel Angiogenic Inhibitor
Derived from Japanese Shark Cartilage (I),
Cancer Letters, vol. 51, pp. 181-186, 1990.
Lee, A., Shark Cartilage Contains Inhibitors
of Tumor Angiogenesis, Science, vol. 221,
pp. 1185-1187, 1983.
Leur, C. A., Inhibitors of Angiogenesis from
Shark Cartilage, Tumor Biology, abstract
4624, p. 949.
D'Amore, P., Antiangiogenesis as a Strategy
for Antimetastasis, Seminars in Thrombosis
& Hemostasis, vol. 14, No. 1, 1988.
Folkman, J. and Klagsburn, M., Angiogenic Factors, Science, vol. 235, pp. 442-447, Jan.
1987.
Oikawa et al, Cancer Letters, vol. 51, pp. 181-186, 1990.
Luer et al, Abstract of Fed. Proc., vol. 45, No. 4, pp. 949, Abstract No. 4624, 1986.
Laue et al, Methods in Enzynology, vol. 182, Chapter 43, pp. 566-587, 1990.
Chabot-Fletcher, M. et al. (1994). "Interleukin-8 Production is Regulated by Protein
Kinase C in Human Keratinocytes". The Journal of Investigative Dermatology 103(4):
509-515.
Folkman, J. and M. Klagsbrun (1987). "Angiogenic Factors". Science. 235: 442-446.
Langer, R et al. (1976). "Isolation of a Cartilage Factor That Inhibits Tumor
Neovascularisation", Science. 193: 70-72.
Lee, A. and R. Langer (1983). "Shark Cartilage Contains Inhibitors of Tumor
Angiogenesis". Science. 221: 1185-1187.
Luer, C.A. (1986). "Inhibitors of Angiogenesis from Shark Cartilage". Fed. Proc. 45(4):
949, Abstract 4624.
Moses, M.A. and R. Langer (1991). "Inhibitors of Angiogenesis". Biotechnology 9:630-
634.
Nickoloff, B.J. et al. (1994). "Aberrant Production of Interleukin-8 and Thrombospondin-
1 Psoriastic Keratinocytes Mediates Angiogenesis". Am. J. Pathology 144(4): 820-828.
Oikawa, T. et al. (1990) "A novel angiogenic inhibitor derived from Japanese shark
cartilage (I). Extraction and estimation of inhibitory activities toward tumor and
embyronic angiogenesis". Cancer Letters 51: 181-186.
Suzuki, F. et al. (1984). "Cartilage-derived Antitumor Factor (CATF): A High Molecular
Weight Fraction in Cartilge Extract Inhibits Solid Tumor Growth". J. of Bone and Mineral
Metabolism 2(3): 3-7.
Moses et al., "Inhibitors of Angiogenesis", Biotechnology (1991) vol. 8, pp. 630-634.
Suzuki et al., "Cartilage-derived Antitumor Factor (CATF): A High Molecular Weight
Fraction in Cartilage Extract Inhibits Solid Tumor Growth", Journal of Bone and Mineral
Metabolism, 1984, vol. 2(3), pp. 3-7.
Luer et al., "Inhibitors of Angiogenesis from Shark Cartilage", 1986, Fed. Proc., vol.
45(4), p. 949 Abstract 4624.
Folkman and Klagsburn. (1987). Science. 235: 442.
Langer et al. (1976). Science. 193: 70.
Lee and Langer. (1983). Science. 221:1185-1187.
Oikawa, T., A Novel Angiogenic Inhibitor Derived from Japanese Shark Cartilage (I),
Cancer Letters, vol. 51, pp. 181-186, 1990.
Lee, A., Shark Cartilage Contains Inhibitors of Tumor Angiogenesis, Science, vol. 221,
pp. 1185-1187, 1983.
Leur, C. A., Inhibitors of Angiogenesis from Shark Cartilage, Tumor Biology, abstract
4624, p. 949.
D'Amore, P., Antiangiogenesis as a Strategy for Antimetastasis, Seminars in Thrombosis
& Hemostasis, vol. 14, No. 1, 1988.
Folkman, J., Vascularization of Tumors, Sci. Am. 234:58-73, 1976.
Folkman, J. and Klagsburn, M., Angiogenic Factors, Science, vol. 235, pp. 442-447, Jan.
1987.
800-434-8152
This document is maintained by
Sea Starr Animal Health, Inc.